COPD
Novartis’ COPD contender cleared in EU
December 4, 2009Sales and Marketing COPD, Novartis, resp
Novartis has been given a green light in the European Union to sell its Onbrez respiratory drug, allowing the firm …
GSK begins phase III COPD trials
October 28, 2009Research and Development, Sales and Marketing COPD, GSK, GlaxoSmithKline, Seretide, Theravance, resp, respiratory
GlaxoSmithKline and San Francisco biopharma firm Theravance have begun a phase III trial to develop a new treatment for chronic …
GP targets drive up COPD prescribing
May 27, 2009Sales and Marketing COPD, NHS, qof
Respiratory drugs saw the biggest growth in GP prescribing in England in 2008, thanks to new COPD targets.The rapid growth …
Phase III drug superior to Spiriva, says Novartis
May 21, 2009Research and Development, Sales and Marketing COPD, Novarits
Novartis says its COPD treatment has shown significant benefits over two established rivals, and could form the cornerstone of a …
Almirall in talks with potential asthma partners
February 26, 2009Sales and Marketing Almirall, COPD
Spanish pharma company Almirall is in discussions with potential partners for one of its asthma drugs following positive trial results. …
Spiriva partners defend drug’s safety
October 2, 2008Sales and Marketing Boehringer, COPD, Spiriva, resp
Boehringer Ingelheim and Pfizer have released new data on Spiriva to defend the safety record of the chronic obstructive pulmonary …
Almirall expands its horizons
July 3, 2008Research and Development, Sales and Marketing Almirall, COPD, Spain
Almirall has been Spain's number one pharmaceutical company for some years, but is still little known outside its home market. …
Groundbreaking pharma-NHS collaboration launched in Nottingham
May 30, 2008ABPI, ABPI Outreach Programme, AstraZeneca, Boehringer Ingelheim, COPD, GlaxoSmithKline, INFORCE, Nottingham, Nycomed, Pfizer, joint working
A group of pharmaceutical companies have joined forces with Nottingham healthcare services to help improve care for patients with chronic …
New antibody could be COPD breakthrough, say companies
November 21, 2005Research and Development Argenta, COPD, Domantis
Two UK biotech companies say their innovative antibody drug could be a breakthrough in treating the chronic respiratory disease COPD.Chronic …
Latest content
Medtronic secures CE Mark for new cardiac pacing portfolio
Dermatology leader Doncker is new Onicor CEO
